Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 06, 2024 08:44 ET | Source: Allied Analytics LLP

E coli Testing Market to Reach $3.9 Billion, Globally, by 2033 at 6.5% CAGR: Allied Market Research

Wilmington, Delaware , Aug. 06, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "E coli Testing Market by Test (Environmental Test, and Clinical Test), and End User...
August 08, 2023 08:15 ET | Source: Transparency Market Research

Vaginitis Diagnostics Market to reach USD 4.1 billion in 2031, expanding at a CAGR of 9.5%: TMR Report

Wilmington, Delaware, United States, Aug. 08, 2023 (GLOBE NEWSWIRE) -- The global vaginitis diagnostics market is projected to flourish at a CAGR of 9.5% from 2022 to 2031. As per the report...
October 25, 2022 12:00 ET | Source: Market Research Future

Clinical Laboratory Test Market Size Worth USD 325 Billion by 2030 at 6.9% CAGR - Report by Market Research Future (MRFR)

New York, USA, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Clinical Laboratory Test Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Clinical Laboratory...
October 19, 2018 20:51 ET | Source: Bionano Genomics; GrandOmics Biosciences

UPDATE – GrandOmics Biosciences Offers Genetic Test Using the Saphyr System for Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD) in China

SAN DIEGO, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and...
October 17, 2018 11:00 ET | Source: Bionano Genomics

Bionano and Genoox Launch Integrated Platform for Identification of Structural Variants in DNA

SAN DIEGO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and...
November 01, 2017 08:00 ET | Source: Bionano Genomics

Bionano Genome Mapping Found to Be Superior to Existing Clinical Tests for the Identification of Pathogenic Structural Variants in Duchenne Muscular Dystrophy

SAN DIEGO, Nov. 01, 2017 (GLOBE NEWSWIRE) -- In a publication in Genome Medicine, a team of researchers from Children’s National Health Center (CNHC) and the University of California, Los Angeles...